Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ADRENACLICK

« Back to Dashboard

Summary for Tradename: ADRENACLICK

Patents:0
Applicants:1
NDAs:1
Suppliers: see list6

Clinical Trials for: ADRENACLICK

A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine
Status: Completed Condition: Anaphylaxis

Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
Status: Completed Condition: Asthma

Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics
Status: Completed Condition: Asthma; Bronchospasm; Wheezing; Shortness of Breath

Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext
Status: Completed Condition: Handling of Auto-injectors

Make up for the Epinephrine Autoinjector
Status: Completed Condition: Anaphylaxis

Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)
Status: Completed Condition: Adrenal Gland Neoplasms; Adrenal Malignancies; Abnormal Hormonal Secretions; Electrolytes Abnormalities

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
Status: Completed Condition: Adrenal Gland Neoplasms

Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
Status: Recruiting Condition: Cardiopulmonary Arrest; Cardiac Arrest

The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine
Status: Completed Condition: Spinal Anesthesia

The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
Status: Not yet recruiting Condition: Croup; Epinephrine Neublizer Treatment

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amedra Pharms
ADRENACLICK
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020800Nov 25, 2009RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc